(Q38075774)

28 August 2017

1 reference

title

Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases (English)

1 reference

28 August 2017

0 references

0 references

R Prieto-Pérez

1

0 references

Francisco Abad-Santos

object named as

F Abad-Santos

series ordinal

4

0 references

author name string

T Cabaleiro

series ordinal

2

1 reference

28 August 2017

E Daudén

series ordinal

3

1 reference

28 August 2017

publication date

22 January 2013

1 reference

The Pharmacogenomics Journal

28 August 2017

published in

1 reference

28 August 2017

volume

13

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

297-305

1 reference

Regulation of cytokines by small RNAs during skin inflammation.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

The genetics of psoriasis, psoriatic arthritis and atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Genetics of psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Psoriasis genetics: breaking the barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Interleukin (IL) 1alpha, IL1beta, IL receptor antagonist, and IL10 polymorphisms in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

DrugBank: a knowledgebase for drugs, drug actions and drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Psoriasis assessment tools in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Prospects for research in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Evidence that cytokines play a role in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Polymorphisms of the IL12B and IL23R genes are associated with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Differences in genetic background between active smokers, passive smokers, and non-smokers with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Investigation of association of the IL12B and IL23R genes with psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

TNFalpha blockade in human diseases: mechanisms and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

New insights into the pathogenesis and genetics of psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

The 5q31 variants associated with psoriasis and Crohn's disease are distinct

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Lack of association or interactions between the IL-4, IL-4Ralpha and IL-13 genes, and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Cytokine imprinting - mechanisms for memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Lack of association between interleukin 23 receptor gene polymorphisms and rheumatoid arthritis susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Cytokine gene polymorphisms in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Interleukin-10 polymorphisms in Spanish patients with IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Anti-p40 antibodies ustekinumab and briakinumab: blockade of interleukin-12 and interleukin-23 in the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Genome-wide association scan in psoriasis: new insights into chronic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Consolidation of Evidence for Association of the KIAA1109-TENR-IL2-IL21 rs6822844 Variant With Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

TNFalpha polymorphisms and risk of psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Associations between tumor necrosis factor-alpha (TNF-alpha) -308 and -238 G/A polymorphisms and shared epitope status and responsiveness to TNF-alpha blockers in rheumatoid arthritis: a metaanalysis update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Lymphotoxin alpha gene in Crohnʼs disease patients: absence of implication in the response to infliximab in a large cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Genetic evidence for involvement of the IL23 pathway in Thai psoriatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Evaluation for psoriatic arthritis in dermatology clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Variants in MHC, LCE and IL12B have epistatic effects on psoriasis risk in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Pharmacogenomics of response to anti-tumor necrosis factor therapy in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Promoter Polymorphisms of the Genes Encoding Tumor Necrosis Factor-α and Interleukin-1β are Associated with Different Subtypes of Psoriasis Characterized by Early and Late Disease Onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Investigation ofIL1,VEGF,PPARGandMEFVgenes in psoriatic arthritis susceptibility: Table 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Association of TNF -238 and -308 Promoter Polymorphisms with Psoriasis Vulgaris and Psoriatic Arthritis but not with Pustulosis Palmoplantaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

TNF polymorphisms in psoriasis: Association of psoriatic arthritis with the promoter polymorphismTNF*-857 independent of thePSORS1 risk allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF B signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

[Study of genetic polymorphisms in the tumor necrosis factor α promoter region in Spanish patients with psoriasis]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

NOD2/CARD15 and TNFA, But Not ILLB and ILLRN, are Associated With Crohnʼs Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.53

21 January 2018

Identifiers

DOI

10.1038/TPJ.2012.53

1 reference

Dimensions Publication ID

28 August 2017

1002646050

0 references

1 reference